Health Bulletin 21/ August/ 2024

Published On 2024-08-21 11:39 GMT   |   Update On 2024-08-21 11:39 GMT

Here are the top health stories for the day:

RG Kar doctor case: Who is Dr. Sandeep Ghosh? ex-colleagues raise several allegations
The former principal of Kolkata's RG Kar Medical College and Hospital, Dr Sandip Ghosh who has been making rounds at the doors of CBI for interrogation is at the centre of controversy after allegations of his being involved with several illegal activities came to light following the brutal rape and murder of a postgraduate student.
Advertisement
The term 'running Mafia-like operation' to define the illegal activities allegedly run by the former principal during his tenure at the RG Kar Medical College and Hospital has become popular in the past few days after his former colleagues decided to come forward with accusations against him.
For more information, click on the link below:
1st-year PGIMS BDS student alleges 7 months of assault by MD student; accused arrested
Amid the nationwide outrage and protest against the rape-murder of a Kolkata doctor, a shocking incident of assault has been reported from Rohtak where a first-year BDS student of Post Graduate Institute of Medical Sciences (PGIMS) was allegedly physically assaulted and harassed for the past 7 months by a resident doctor of MD Anatomy first year.
According to the student's statement, the accused doctor was stalking her and persistently pressured her to enter into a relationship. However, when she refused, the alleged assault, harassment and torture began. Although the alleged harassment started 7 months ago, it came to light when she shared a note on social media revealing her disturbing and traumatic experience that took place on August 16 and 17.
For more information, click on the link below:
NPPA sets retail prices of 70 formulations
Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, the Government of India, has fixed retail prices of 70 formulations under the Drugs (Prices Control) Order, 2013.
This came in line with the decision of the 125th Authority meeting dated 25.07.2024 where the authority discussed new drug applications for price fixations under para 5 and para 15 of DPCO 2013.
For more information, click on the link below:
Centre: AB-PMJAY provides free hospital care to 7.4 crore patients
As of June 30, 2024, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) has authorized 7.37 crore hospital admissions totalling ₹1 lakh crore, according to the latest data from the Ministry of Health. The scheme is active across 33 states and Union Territories.
According to an IANS report, the leading states in which Ayushman cards have been created under the PMJAY scheme include Madhya Pradesh with 402.5 lakh cards, Maharashtra (280 lakh), Karnataka (171.5 lakh) Jammu and Kashmir (85.9 lakh), Telangana (82.5 lakh), Tamil Nadu (73.6 lakh) and Meghalaya (19.76 lakh).
For more information, click on the link below:
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News